- Home
- TURN vs CNTB Comparison
TURN vs CNTB Comparison
Compare TURN & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- CNTB
- Stock Information
- Founded
- TURN 1981
- CNTB 2012
- Country
- TURN United States
- CNTB United States
- Employees
- TURN N/A
- CNTB N/A
- Industry
- TURN Finance/Investors Services
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- TURN Finance
- CNTB Health Care
- Exchange
- TURN Nasdaq
- CNTB Nasdaq
- Market Cap
- TURN 46.3M
- CNTB 54.4M
- IPO Year
- TURN N/A
- CNTB 2021
- Fundamental
- Price
- TURN $4.98
- CNTB $2.06
- Analyst Decision
- TURN
- CNTB Strong Buy
- Analyst Count
- TURN 0
- CNTB 2
- Target Price
- TURN N/A
- CNTB $7.50
- AVG Volume (30 Days)
- TURN 22.0K
- CNTB 131.1K
- Earning Date
- TURN 02-26-2018
- CNTB 08-13-2025
- Dividend Yield
- TURN N/A
- CNTB N/A
- EPS Growth
- TURN N/A
- CNTB N/A
- EPS
- TURN 0.30
- CNTB N/A
- Revenue
- TURN $488,011.00
- CNTB $1,965,000.00
- Revenue This Year
- TURN N/A
- CNTB N/A
- Revenue Next Year
- TURN N/A
- CNTB N/A
- P/E Ratio
- TURN $16.69
- CNTB N/A
- Revenue Growth
- TURN 254.25
- CNTB N/A
- 52 Week Low
- TURN $3.12
- CNTB $0.51
- 52 Week High
- TURN $4.98
- CNTB $2.86
- Technical
- Relative Strength Index (RSI)
- TURN 81.01
- CNTB 56.35
- Support Level
- TURN $4.51
- CNTB $1.70
- Resistance Level
- TURN $4.74
- CNTB $1.92
- Average True Range (ATR)
- TURN 0.12
- CNTB 0.22
- MACD
- TURN 0.04
- CNTB -0.03
- Stochastic Oscillator
- TURN 100.00
- CNTB 53.49
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.